STOCK TITAN

BRUKER (BRKR) SEC Filings, Nov 2025-Feb 2026

BRKR NASDAQ

Bruker Corporation filings document financial results, capital returns, governance actions and proxy matters for a scientific instruments and diagnostics company.

Recent Form 8-K disclosures cover quarterly and annual operating results, outlook commentary, segment information for Bruker Scientific Instruments and Bruker Energy & Supercon Technologies, and dividends on common stock and 6.375% Mandatory Convertible Preferred Stock, Series A. The definitive proxy statement covers board elections, executive compensation, pay-versus-performance data, shareholder voting items and governance practices. Other material-event filings record board composition changes and executive transition arrangements.

Rhea-AI Summary

T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G/A reporting its beneficial ownership of 4,594,398 shares of Bruker Corp common stock, representing 3.0% of the class as of 12/31/2025. The firm has sole voting power over 4,584,656 shares and sole dispositive power over 4,594,398 shares, with no shared voting or dispositive power. The filing states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Bruker. The filer also affirms that this should not be construed as an admission of beneficial ownership, which is expressly denied.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.41%
Tags
ownership
-
Rhea-AI Summary

A holder of BRKR common stock has filed a notice to sell 2,000 shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $73,880. The shares are listed on NASDAQ, and the filing states 151,941,144 shares of this class are outstanding.

The 2,000 shares to be sold were acquired on 02/13/2026 via a stock option exercise from the issuer, paid in cash the same day. The person named in recent activity, Mark R. Munch, has already sold common shares in the past three months, including 2,000 shares on 01/15/2026 for $98,400, 7,000 shares on 01/12/2026 for $385,000, and 33,843 shares on 01/05/2026 for $1,680,704.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.41%
Tags
other
-
Rhea-AI Summary

Bruker Corporation reported a challenging 2025, with modest growth but weaker profitability and a GAAP loss. Full-year revenue rose to $3.44 billion, up 2.1% from 2024, yet organic revenue fell 3.7%. Q4-25 revenue was $977.2 million, essentially flat year-over-year.

GAAP operating income dropped to $68.2 million for 2025 from $253.1 million, driven by $127.2 million of goodwill and intangible impairments and $77.4 million of restructuring charges. GAAP diluted loss per share was $(0.15), while non-GAAP diluted EPS was $1.83, down from $2.41.

Management initiated 2026 guidance calling for revenue of $3.57–$3.60 billion, implying 4%–5% growth, with 1%–2% organic growth and non-GAAP EPS of $2.10–$2.15, 15%–17% above 2025 despite an estimated 8% foreign-exchange headwind.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.60%
Tags
current report
Rhea-AI Summary

Bruker Corporation executive Mark Munch reported an options exercise and share sale. On 01/15/2026 he exercised stock options for 2,000 shares of common stock at $22.19 per share, then sold 2,000 shares of common stock at $49.20 per share on the same date. The filing states that the sales were made under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person. After these transactions, he beneficially owned 128,443 shares of Bruker common stock directly, along with 16,000 stock options that remain outstanding.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.00%
Tags
insider
-
Rhea-AI Summary

Bruker Corporation insider Mark R. Munch has filed a Rule 144 notice to sell 2,000 shares of the company’s common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate sale date of 01/15/2026 and an aggregate market value of $98,400. The securities were acquired on 01/15/2026 by exercising stock options granted by the issuer and were paid for in cash.

Over the prior three months, the same seller reported additional open-market sales of Bruker common stock. On 01/12/2026, 7,000 shares were sold for gross proceeds of $385,000, and on 01/05/2026, 33,843 shares were sold for gross proceeds of $1,680,704. The notice includes a representation that the seller does not know any material adverse, non-public information about Bruker’s current or prospective operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.16%
Tags
other
-
Rhea-AI Summary

Bruker Corporation executive Mark Munch, EVP & President of Bruker Nano Inc., reported an option exercise and share sale in a Form 4. On January 12, 2026, he exercised a stock option for 7,000 shares of common stock at $22.19 per share, then sold 7,000 common shares at $55 per share on the same day. After these transactions, he directly owned 128,443 shares of Bruker common stock and held 18,000 stock options. The filing notes that the sales were made under a Rule 10b5-1 trading plan previously adopted by Munch.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.42%
Tags
insider
Rhea-AI Summary

The Form 144 notice for Bruker Corporation discloses an intended sale of 7,000 shares of common stock through Morgan Stanley Smith Barney LLC on or about 01/12/2026 on the NASDAQ. The shares have an indicated aggregate market value of $385,000, compared with 151,941,144 shares of common stock outstanding. The 7,000 shares are shown as acquired on 01/12/2026 from the issuer via a stock option exercise paid in cash for the same amount of shares.

The filing also reports that over the prior three months, Mark R. Munch sold 33,843 shares of Bruker common stock on 01/05/2026, generating $1,680,704 in gross proceeds. The form includes the standard representation that the seller does not know of any undisclosed material adverse information about the issuer’s current or prospective operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.74%
Tags
other
-
Rhea-AI Summary

Bruker Corporation released preliminary figures for its fourth quarter ended December 31, 2025 and shared its outlook for 2026 during a presentation at the J.P. Morgan Healthcare Conference. The company currently expects Q4 2025 revenue between $965 million and $970 million, and reported that its Bruker Scientific Instruments segments had a book-to-bill ratio above 1.0, indicating orders exceeded revenue in the period.

For the full year 2026, Bruker is targeting organic revenue growth of flat to up low-single digits, expansion of non-GAAP organic operating margins by 250 to 300 basis points, and non-GAAP earnings per share growth in the double-digits, all compared to 2025. The company emphasized that these figures are preliminary, unaudited and subject to change as year-end closing and audit procedures are completed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
current report
-
Rhea-AI Summary

Bruker Corp director files initial ownership report showing no holdings

Director Jack Phillips filed a Form 3 as an initial statement of beneficial ownership of securities for Bruker Corp (BRKR). The filing lists his relationship to the company as a director and confirms that the form is filed by one reporting person. In the explanatory section, he reports that no securities are beneficially owned as of the event date of 01/01/2026. The Form 3 was signed on 01/09/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.93%
Tags
insider
Rhea-AI Summary

Bruker Corporation (BRKR): Director insider transaction reported. On 11/06/2025, a director exercised stock options for 10,000 shares of common stock at $24 per share (Code M) and sold 6,233 shares (Code S) at a weighted average price of $39. The sale occurred in multiple trades within a range of $39.0001 to $39.0101.

Following these transactions, the director beneficially owned 35,212 shares directly. A related stock option originally granted on January 5, 2016, vested over three years and carries an expiration date of 01/05/2026. After the reported transactions, 10,000 derivative securities (stock options) were listed as beneficially owned.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.33%
Tags
insider

FAQ

How many BRUKER (BRKR) SEC filings are available on StockTitan?

StockTitan tracks 100 SEC filings for BRUKER (BRKR), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for BRUKER (BRKR)?

The most recent SEC filing for BRUKER (BRKR) was filed on November 16, 2026.